Machine learning for genetic prediction of psychiatric disorders: a systematic review.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
01 2021
Historique:
received: 15 05 2020
accepted: 16 06 2020
revised: 09 06 2020
pubmed: 28 6 2020
medline: 15 4 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

Machine learning methods have been employed to make predictions in psychiatry from genotypes, with the potential to bring improved prediction of outcomes in psychiatric genetics; however, their current performance is unclear. We aim to systematically review machine learning methods for predicting psychiatric disorders from genetics alone and evaluate their discrimination, bias and implementation. Medline, PsycInfo, Web of Science and Scopus were searched for terms relating to genetics, psychiatric disorders and machine learning, including neural networks, random forests, support vector machines and boosting, on 10 September 2019. Following PRISMA guidelines, articles were screened for inclusion independently by two authors, extracted, and assessed for risk of bias. Overall, 63 full texts were assessed from a pool of 652 abstracts. Data were extracted for 77 models of schizophrenia, bipolar, autism or anorexia across 13 studies. Performance of machine learning methods was highly varied (0.48-0.95 AUC) and differed between schizophrenia (0.54-0.95 AUC), bipolar (0.48-0.65 AUC), autism (0.52-0.81 AUC) and anorexia (0.62-0.69 AUC). This is likely due to the high risk of bias identified in the study designs and analysis for reported results. Choices for predictor selection, hyperparameter search and validation methodology, and viewing of the test set during training were common causes of high risk of bias in analysis. Key steps in model development and validation were frequently not performed or unreported. Comparison of discrimination across studies was constrained by heterogeneity of predictors, outcome and measurement, in addition to sample overlap within and across studies. Given widespread high risk of bias and the small number of studies identified, it is important to ensure established analysis methods are adopted. We emphasise best practices in methodology and reporting for improving future studies.

Identifiants

pubmed: 32591634
doi: 10.1038/s41380-020-0825-2
pii: 10.1038/s41380-020-0825-2
pmc: PMC7610853
mid: EMS125581
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-79

Subventions

Organisme : Medical Research Council
ID : G0801418
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T04604X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom

Références

BioData Min. 2013 Mar 01;6(1):5
pubmed: 23448398
J Med Internet Res. 2016 Dec 16;18(12):e323
pubmed: 27986644
J Clin Epidemiol. 2001 Aug;54(8):774-81
pubmed: 11470385
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Genetics. 2012 Dec;192(4):1327-45
pubmed: 22982579
Am J Med Genet B Neuropsychiatr Genet. 2019 Jan;180(1):80-85
pubmed: 30516002
Curr Top Med Chem. 2013;13(5):675-84
pubmed: 23548028
Schizophr Bull. 2018 Aug 20;44(5):1045-1052
pubmed: 29534239
Heart. 2012 May;98(9):683-90
pubmed: 22397945
Int J Epidemiol. 2012 Dec;41(6):1798-806
pubmed: 23148107
Mol Psychiatry. 2019 Nov;24(11):1583-1598
pubmed: 30770893
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Hum Genet. 2020 Jan;139(1):73-84
pubmed: 31049651
Nat Rev Genet. 2009 Jun;10(6):392-404
pubmed: 19434077
Ann Intern Med. 2019 Jan 1;170(1):51-58
pubmed: 30596875
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Asian J Psychiatr. 2019 Aug;44:A1-A4
pubmed: 31530438
Neurosci Biobehav Rev. 2017 Sep;80:538-554
pubmed: 28728937
J Oral Pathol Med. 2019 Oct;48(9):773-779
pubmed: 30908732
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
Lancet. 2019 Apr 20;393(10181):1577-1579
pubmed: 31007185
Psychiatr Genet. 2012 Apr;22(2):55-61
pubmed: 22081063
Hum Mutat. 2017 Sep;38(9):1182-1192
pubmed: 28634997
J Clin Epidemiol. 2019 Jun;110:12-22
pubmed: 30763612
BMC Med Res Methodol. 2008 Jul 21;8:48
pubmed: 18644127
J Clin Epidemiol. 1996 Aug;49(8):907-16
pubmed: 8699212
Int J Epidemiol. 2006 Feb;35(1):34-41
pubmed: 16155052
Schizophr Bull. 2018 Aug 20;44(5):939-941
pubmed: 29986110
Nature. 2014 Feb 13;506(7487):185-90
pubmed: 24463508
Hum Mol Genet. 2008 Oct 15;17(R2):R143-50
pubmed: 18852203
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Nat Mater. 2019 May;18(5):422-427
pubmed: 30478452
Am J Hum Genet. 2017 Apr 6;100(4):635-649
pubmed: 28366442
Genome Med. 2011 Mar 15;3(3):16
pubmed: 21410995
BMC Med Genomics. 2016 Jan 20;9:4
pubmed: 26792494
J Affect Disord. 2018 Dec 1;241:519-532
pubmed: 30153635
Comput Methods Programs Biomed. 2020 Jul;191:105320
pubmed: 32088490
Methods Mol Biol. 2010;609:223-39
pubmed: 20221922
Mol Psychiatry. 2012 Dec;17(12):1174-9
pubmed: 22869033
Schizophr Res. 2019 Dec;214:34-42
pubmed: 29074332
Am J Med Genet B Neuropsychiatr Genet. 2019 Mar;180(2):103-112
pubmed: 29704323
BMC Bioinformatics. 2006 Feb 23;7:91
pubmed: 16504092
Nat Commun. 2015 Jun 25;6:7432
pubmed: 26109276
Trends Genet. 2018 Apr;34(4):301-312
pubmed: 29331490
PLoS Genet. 2010 Feb 26;6(2):e1000864
pubmed: 20195508
Molecules. 2010 Jul 12;15(7):4875-89
pubmed: 20657396
PLoS One. 2019 Nov 7;14(11):e0224365
pubmed: 31697686
PLoS Med. 2014 Oct 14;11(10):e1001744
pubmed: 25314315
Science. 2018 Dec 14;362(6420):
pubmed: 30545857
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
BMC Med Genomics. 2015;8 Suppl 1:S7
pubmed: 25783485
Schizophr Bull. 2017 May 1;43(3):473-475
pubmed: 28338845
BMJ. 2015 Aug 11;351:h3868
pubmed: 26264962
Front Hum Neurosci. 2010 Oct 25;4:192
pubmed: 21119772
Hum Mutat. 2017 Sep;38(9):1217-1224
pubmed: 28600868
Genomics. 2012 Jun;99(6):323-9
pubmed: 22546560
Mol Psychiatry. 2014 Apr;19(4):405-7
pubmed: 23546168
PLoS One. 2011 May 12;6(5):e14802
pubmed: 21589856
Biochem Med (Zagreb). 2018 Feb 15;28(1):010101
pubmed: 29209139
Mol Biol Evol. 2019 Feb 1;36(2):220-238
pubmed: 30517664
Psychol Med. 2016 Sep;46(12):2455-65
pubmed: 27406289
J Neuroimmune Pharmacol. 2018 Dec;13(4):532-540
pubmed: 30276764
Hum Genet. 2014 May;133(5):639-50
pubmed: 24337655
J Mol Neurosci. 2019 Aug;68(4):515-521
pubmed: 30937628
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Front Genet. 2019 Mar 27;10:267
pubmed: 30972108
BMJ. 2017 Jan 5;356:i6460
pubmed: 28057641
Eur J Hum Genet. 2011 May;19(5):18 p preceding 494
pubmed: 21407270
Nat Genet. 2004 May;36(5):512-7
pubmed: 15052271
Neuropsychiatr Dis Treat. 2016 Nov 24;12:2997-3004
pubmed: 27920536

Auteurs

Matthew Bracher-Smith (M)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Karen Crawford (K)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK.

Valentina Escott-Price (V)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK. escottpricev@cardiff.ac.uk.
Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK. escottpricev@cardiff.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH